Once the intravenous tPA infusion was started, the patient was transferred via air ambulance to a comprehensive stroke center ... demonstrated ischemic changes confined predominantly to the ...

The MERCI®retrieval device and the Penumbra Stroke System®are US FDA-approved endovascular devices for thrombectomy in acute ischemic stroke due to cerebral vascular occlusions. Widespread ...

US-based Penumbra has completed enrolment for the THUNDER Investigational Device Exemption study of its advanced thrombectomy technology for acute ischemic stroke treatment. This study will ...

ALAMEDA, Calif., Oct. 14, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for patients ...

In the assessment of 12-month price targets, analysts unveil insights for Penumbra, presenting an average target of $237.18, ...

ALAMEDA, Calif., Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare conference on ...